Therapeutic Asset Ratings

3,186 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
her2bbζ/cd19t+ t cells Acute Myeloid Leukemia	David Avigan	P1/2	C (33)
her2bbζ/cd19t+ t cells Hepatocellular Carcinoma	Shanghai Public Health Clinical Center	P1/2	C (33)
Bcma-Cd19 Ccar T Cells Systemic Sclerosis	Peking University People's Hospital	P2	C (32)
cd22 car-transduced t cells Lymphoma	Liping Dou	P2	C (32)
Anti-Egfr-Bispecific Antibody Armed Activated T-Cells Pancreatic Adenocarcinoma	Memorial Sloan Kettering Cancer Center	P1	C (32)
Anti-Egfr-Bispecific Antibody Armed Activated T-Cells Pancreatic Neoplasm	Memorial Sloan Kettering Cancer Center	P1	C (32)
Arm 1: Il13Ra2-Specific Car Tcm Cells Glioblastoma	City of Hope Medical Center	P1	C (32)
Arm 2: Il13Ra2-Specific Car Tcm Cells Glioblastoma	City of Hope Medical Center	P1	C (32)
Arm 3: Il13Ra2-Specific Car Tcm Cells Glioblastoma	City of Hope Medical Center	P1	C (32)
Arm 4: Il13Ra2-Specific Car Tcm Cells Glioblastoma	City of Hope Medical Center	P1	C (32)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes High Grade B-Cell Lymphoma	City of Hope Medical Center	P1	C (32)
cd22 car-transduced t cells Precursor B-Cell Acute Lymphoblastic Leukemia	National Cancer Institute (NCI)	P1	C (32)
P-Cd19Cd20-Allo1 High Grade B-Cell Lymphoma	Poseida Therapeutics, Inc.	P1	C (32)
Rivogenlecleucel Hematopoietic And Lymphoid System Neoplasm	Bellicum Pharmaceuticals	P1	C (32)
Rivogenlecleucel Leukemia	Bellicum Pharmaceuticals	P1	C (32)
Rivogenlecleucel Plasma Cell Myeloma	Bellicum Pharmaceuticals	P1	C (32)
Unicar02-T Prostate Cancer	AvenCell Therapeutics, Inc.	P1	C (32)
Anti-Cd19 Car Nk Cells B-Cell Non-Hodgkin Lymphoma	Xuzhou Medical University	Early P1	C (32)
cta101 Non-Hodgkin Lymphoma	He Huang	Early P1	C (32)
cta30x ucar-t B-Cell Non-Hodgkin Lymphoma	920th Hospital of Joint Logistics Support Force of People's Liberation Army of China	Early P1	C (32)
her2bbζ/cd19t+ t cells Systemic Sclerosis	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	Early P1	C (32)
Metabolically Armed Cd19 Car-T Cells Non-Hodgkin Lymphoma	The Children's Hospital of Zhejiang University School of Medicine	Early P1	C (32)
cd22 car-transduced t cells Follicular Lymphoma	Essen Biotech	P1/2	C (32)
gpc3-car-t cells Squamous Cell Lung Carcinoma	Sotio Biotech Inc.	P1/2	C (32)
her2bbζ/cd19t+ t cells Small Cell Lung Carcinoma	Shanghai Public Health Clinical Center	P1/2	C (32)

Showing 2551 to 2575 of 3,186 assets

PreviousPage 103 of 128Next